This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Funahashi, Y. Articles by Kitajewski, J. Search for Related Content PubMed PubMed Citation Articles by Funahashi, Y. Articles by Kitajewski, J.

A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis

Departments of ¹ Obstetrics and Gynaecology, ² Pathology, ³ Nutrition, ⁴ Pediatrics, and ⁵ Surgery, ⁶ Institute of Cancer Genetics, Columbia University Medical Center, New York, New York; and ⁷ Tohoku University Medical Center, Sendai, Japan

Requests for reprints: Jan Kitajewski, 1130 St. Nicholas Avenue, Irving Cancer Research Center, New York, NY 10032. Phone: 212-851-4688; Fax: 212-851-4690; E-mail: jkk9{at}columbia.edu.

Key Words: Notch • decoy • Jagged1 • fibroblast growth factor • angiogenesis

Notch signaling is required for vascular development and tumor angiogenesis. Although inhibition of the Notch ligand Delta-like 4 can restrict tumor growth and disrupt neovasculature, the effect of inhibiting Notch receptor function on angiogenesis has yet to be defined. In this study, we generated a soluble form of the Notch1 receptor (Notch1 decoy) and assessed its effect on angiogenesis in vitro and in vivo. Notch1 decoy expression reduced signaling stimulated by the binding of three distinct Notch ligands to Notch1 and inhibited morphogenesis of endothelial cells overexpressing Notch4. Thus, Notch1 decoy functioned as an antagonist of ligand-dependent Notch signaling. In mice, Notch1 decoy also inhibited vascular endothelial growth factor–induced angiogenesis in skin, establishing a role for Notch receptor function in this process. We tested the effects of Notch1 decoy on tumor angiogenesis using two models: mouse mammary Mm5MT cells overexpressing fibroblast growth factor 4 (Mm5MT-FGF4) and NGP human neuroblastoma cells. Exogenously expressed FGF4 induced Notch ligand expression in Mm5MT cells and xenografts. Notch1 decoy expression did not affect tumorigenicity of Mm5MT-FGF4 cells in vitro but restricted Mm5MT-FGF4 xenograft growth in mice while markedly impairing neoangiogenesis. Similarly, Notch1 decoy expression did not affect NGP cells in vitro but disrupted vessels and decreased tumor viability in vivo. These results strongly suggest that Notch receptor signaling is required for tumor neoangiogenesis and provides a new target for tumor therapy. [Cancer Res 2008;68(12):4727–35]

This article has been cited by other articles:

				L. Qiao and B. C.Y. Wong Role of Notch signaling in colorectal cancer Carcinogenesis, December 1, 2009; 30(12): 1979 - 1986. [Abstract] [Full Text] [PDF]

				L. Luistro, W. He, M. Smith, K. Packman, M. Vilenchik, D. Carvajal, J. Roberts, J. Cai, W. Berkofsky-Fessler, H. Hilton, et al. Preclinical Profile of a Potent {gamma}-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties Cancer Res., October 1, 2009; 69(19): 7672 - 7680. [Abstract] [Full Text] [PDF]